{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:59Z","timestamp":1707525119628},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,30]]},"DOI":"10.7759\/cureus.38353","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T01:35:22Z","timestamp":1682904922000},"source":"Crossref","is-referenced-by-count":1,"title":["Radiological Biomarkers for Brain Metastases Prognosis: Quantitative Magnetic Resonance Imaging (MRI) Modalities As Non-invasive Biomarkers for the Effect of Radiotherapy"],"prefix":"10.7759","author":[{"given":"Akram M","family":"Eraky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab101","article-title":"Epidemiology of brain metastases and leptomeningeal disease","volume":"23","author":"Lamba N","year":"2021","unstructured":"Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 2021, 23:1447-56. 10.1093\/neuonc\/noab101","journal-title":"Neuro Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2104111","article-title":"Serum long non-coding RNAs as potential noninvasive biomarkers for glioblastoma diagnosis, prognosis, and chemoresistance","volume":"21","author":"Eraky AM","year":"2022","unstructured":"Eraky AM, Keles A, Goodman SL, Baskaya MK. Serum long non-coding RNAs as potential noninvasive biomarkers for glioblastoma diagnosis, prognosis, and chemoresistance. J Integr Neurosci. 2022, 21:111. 10.31083\/j.jin2104111","journal-title":"J Integr Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34593","article-title":"Non-coding RNAs as genetic biomarkers for the diagnosis, prognosis, radiosensitivity, and histopathologic grade of meningioma","volume":"15","author":"Eraky AM","year":"2023","unstructured":"Eraky AM. Non-coding RNAs as genetic biomarkers for the diagnosis, prognosis, radiosensitivity, and histopathologic grade of meningioma. Cureus. 2023, 15:e34593. 10.7759\/cureus.34593","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36337","article-title":"Advances in brain metastases diagnosis: non-coding RNAs as potential biomarkers","volume":"15","author":"Eraky AM","year":"2023","unstructured":"Eraky AM. Advances in brain metastases diagnosis: non-coding RNAs as potential biomarkers. Cureus. 2023, 15:e36337. 10.7759\/cureus.36337","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17707398","article-title":"Implications of neurovascular uncoupling in functional magnetic resonance imaging (fMRI) of brain tumors","volume":"37","author":"Pak RW","year":"2017","unstructured":"Pak RW, Hadjiabadi DH, Senarathna J, Agarwal S, Thakor NV, Pillai JJ, Pathak AP. Implications of neurovascular uncoupling in functional magnetic resonance imaging (fMRI) of brain tumors. J Cereb Blood Flow Metab. 2017, 37:3475-87. 10.1177\/0271678X17707398","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.20913","article-title":"Functional MR imaging of the female pelvis","volume":"25","author":"Koyama T","year":"2007","unstructured":"Koyama T, Togashi K. Functional MR imaging of the female pelvis. J Magn Reson Imaging. 2007, 25:1101-12. 10.1002\/jmri.20913","journal-title":"J Magn Reson Imaging"},{"key":"ref7","article-title":"Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors","volume":"7","author":"Jiang J","year":"2014","unstructured":"Jiang J, Zhao L, Zhang Y, et al.. Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors. Int J Clin Exp Pathol. 2014, 7:2790-9.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03475-y","article-title":"Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma","volume":"147","author":"Manning P","year":"2020","unstructured":"Manning P, Daghighi S, Rajaratnam MK, et al.. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma. J Neurooncol. 2020, 147:681-90. 10.1007\/s11060-020-03475-y","journal-title":"J Neurooncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.25530","article-title":"Comparison of conventional DCE-MRI and a novel golden-angle radial multicoil compressed sensing method for the evaluation of breast lesion conspicuity","volume":"45","author":"Heacock L","year":"2017","unstructured":"Heacock L, Gao Y, Heller SL, et al.. Comparison of conventional DCE-MRI and a novel golden-angle radial multicoil compressed sensing method for the evaluation of breast lesion conspicuity. J Magn Reson Imaging. 2017, 45:1746-52. 10.1002\/jmri.25530","journal-title":"J Magn Reson Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2011.22.4.275","article-title":"Diffusion-weighted MR imaging in gynecologic cancers","volume":"22","author":"Motoshima S","year":"2011","unstructured":"Motoshima S, Irie H, Nakazono T, Kamura T, Kudo S. Diffusion-weighted MR imaging in gynecologic cancers. J Gynecol Oncol. 2011, 22:275-87. 10.3802\/jgo.2011.22.4.275","journal-title":"J Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1971400918783058","article-title":"Arterial spin labeling perfusion: prospective MR imaging in differentiating neoplastic from non-neoplastic intra-axial brain lesions","volume":"31","author":"Soni N","year":"2018","unstructured":"Soni N, Srindharan K, Kumar S, Mishra P, Bathla G, Kalita J, Behari S. Arterial spin labeling perfusion: prospective MR imaging in differentiating neoplastic from non-neoplastic intra-axial brain lesions. Neuroradiol J. 2018, 31:544-53. 10.1177\/1971400918783058","journal-title":"Neuroradiol J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.01.005","article-title":"Early development of arterial spin labeling to measure regional brain blood flow by MRI","volume":"62","author":"Koretsky AP","year":"2012","unstructured":"Koretsky AP. Early development of arterial spin labeling to measure regional brain blood flow by MRI. Neuroimage. 2012, 62:602-7. 10.1016\/j.neuroimage.2012.01.005","journal-title":"Neuroimage"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/RMR.0b013e31821e53f5","article-title":"Perfusion MRI using dynamic-susceptibility contrast MRI: quantification issues in patient studies","volume":"21","author":"Calamante F","year":"2010","unstructured":"Calamante F. Perfusion MRI using dynamic-susceptibility contrast MRI: quantification issues in patient studies. Top Magn Reson Imaging. 2010, 21:75-85. 10.1097\/RMR.0b013e31821e53f5","journal-title":"Top Magn Reson Imaging"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4458","article-title":"Dynamic contrast-enhanced MR imaging in head and neck cancer: techniques and clinical applications","volume":"37","author":"Gaddikeri S","year":"2016","unstructured":"Gaddikeri S, Gaddikeri RS, Tailor T, Anzai Y. Dynamic contrast-enhanced MR imaging in head and neck cancer: techniques and clinical applications. AJNR Am J Neuroradiol. 2016, 37:588-95. 10.3174\/ajnr.A4458","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2016.07.005","article-title":"Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor","volume":"85","author":"Lu S","year":"2016","unstructured":"Lu S, Gao Q, Yu J, Li Y, Cao P, Shi H, Hong X. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor. Eur J Radiol. 2016, 85:1722-7. 10.1016\/j.ejrad.2016.07.005","journal-title":"Eur J Radiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/ANA.0b013e31815d4c70","article-title":"Human cerebral blood volume (CBV) measured by dynamic susceptibility contrast MRI and 99mTc-RBC SPECT","volume":"20","author":"Engvall C","year":"2008","unstructured":"Engvall C, Ryding E, Wirestam R, Holt\u00e5s S, Ljunggren K, Ohlsson T, Reinstrup P. Human cerebral blood volume (CBV) measured by dynamic susceptibility contrast MRI and 99mTc-RBC SPECT. J Neurosurg Anesthesiol. 2008, 20:41-4. 10.1097\/ANA.0b013e31815d4c70","journal-title":"J Neurosurg Anesthesiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00062-013-0255-5","article-title":"Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"24","author":"Xing Z","year":"2014","unstructured":"Xing Z, You RX, Li J, Liu Y, Cao DR. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Clin Neuroradiol. 2014, 24:329-36. 10.1007\/s00062-013-0255-5","journal-title":"Clin Neuroradiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.22445","article-title":"Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons","volume":"64","author":"Bedekar D","year":"2010","unstructured":"Bedekar D, Jensen T, Schmainda KM. Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons. Magn Reson Med. 2010, 64:907-13. 10.1002\/mrm.22445","journal-title":"Magn Reson Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2020.04.003","article-title":"Golden-Angle Radial Sparse Parallel (GRASP) MRI differentiates head and neck paragangliomas from schwannomas","volume":"70","author":"Demerath T","year":"2020","unstructured":"Demerath T, Blackham K, Anastasopoulos C, Block KT, Stieltjes B, Schubert T. Golden-Angle Radial Sparse Parallel (GRASP) MRI differentiates head and neck paragangliomas from schwannomas. Magn Reson Imaging. 2020, 70:73-80. 10.1016\/j.mri.2020.04.003","journal-title":"Magn Reson Imaging"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.24980","article-title":"Golden-angle radial sparse parallel MRI: combination of compressed sensing, parallel imaging, and golden-angle radial sampling for fast and flexible dynamic volumetric MRI","volume":"72","author":"Feng L","year":"2014","unstructured":"Feng L, Grimm R, Block KT, et al.. Golden-angle radial sparse parallel MRI: combination of compressed sensing, parallel imaging, and golden-angle radial sampling for fast and flexible dynamic volumetric MRI. Magn Reson Med. 2014, 72:707-17. 10.1002\/mrm.24980","journal-title":"Magn Reson Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7243","article-title":"Differentiation of jugular foramen paragangliomas versus schwannomas using golden-angle radial sparse parallel dynamic contrast-enhanced MRI","volume":"42","author":"Pires A","year":"2021","unstructured":"Pires A, Nayak G, Zan E, Hagiwara M, Gonen O, Fatterpekar G. Differentiation of jugular foramen paragangliomas versus schwannomas using golden-angle radial sparse parallel dynamic contrast-enhanced MRI. AJNR Am J Neuroradiol. 2021, 42:1847-52. 10.3174\/ajnr.A7243","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.8510","article-title":"Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management","volume":"198","author":"Verma S","year":"2012","unstructured":"Verma S, Turkbey B, Muradyan N, et al.. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol. 2012, 198:1277-88. 10.2214\/AJR.12.8510","journal-title":"AJR Am J Roentgenol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26732","article-title":"Dynamic contrast-enhanced magnetic resonance imaging for differentiating head and neck paraganglioma and schwannoma","volume":"43","author":"Malla SR","year":"2021","unstructured":"Malla SR, Bhalla AS, Manchanda S, et al.. Dynamic contrast-enhanced magnetic resonance imaging for differentiating head and neck paraganglioma and schwannoma. Head Neck. 2021, 43:2611-22. 10.1002\/hed.26732","journal-title":"Head Neck"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2231010594","article-title":"Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging","volume":"223","author":"Cha S","year":"2002","unstructured":"Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002, 223:11-29. 10.1148\/radiol.2231010594","journal-title":"Radiology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jon.12959","article-title":"MR diffusion and dynamic-contrast enhanced imaging to distinguish meningioma, paraganglioma, and schwannoma in the cerebellopontine angle and jugular foramen","volume":"32","author":"Ota Y","year":"2022","unstructured":"Ota Y, Liao E, Capizzano AA, et al.. MR diffusion and dynamic-contrast enhanced imaging to distinguish meningioma, paraganglioma, and schwannoma in the cerebellopontine angle and jugular foramen. J Neuroimaging. 2022, 32:502-10. 10.1111\/jon.12959","journal-title":"J Neuroimaging"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.177.3.1770709","article-title":"Diffusion-weighted MR imaging of rim-enhancing brain masses: is markedly decreased water diffusion specific for brain abscess?","volume":"177","author":"Tung GA","year":"2001","unstructured":"Tung GA, Evangelista P, Rogg JM, Duncan JA 3rd. Diffusion-weighted MR imaging of rim-enhancing brain masses: is markedly decreased water diffusion specific for brain abscess?. AJR Am J Roentgenol. 2001, 177:709-12. 10.2214\/ajr.177.3.1770709","journal-title":"AJR Am J Roentgenol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.173.6.10584783","article-title":"Diffusion-weighted MR imaging in acute stroke: theoretic considerations and clinical applications","volume":"173","author":"Provenzale JM","year":"1999","unstructured":"Provenzale JM, Sorensen AG. Diffusion-weighted MR imaging in acute stroke: theoretic considerations and clinical applications. AJR Am J Roentgenol. 1999, 173:1459-67. 10.2214\/ajr.173.6.10584783","journal-title":"AJR Am J Roentgenol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2017.12.007","article-title":"Diagnostic value of early postoperative MRI and diffusion-weighted imaging following trans-sphenoidal resection of non-functioning pituitary macroadenomas","volume":"73","author":"Hassan HA","year":"2018","unstructured":"Hassan HA, Bessar MA, Herzallah IR, Laury AM, Arnaout MM, Basha MA. Diagnostic value of early postoperative MRI and diffusion-weighted imaging following trans-sphenoidal resection of non-functioning pituitary macroadenomas. Clin Radiol. 2018, 73:535-41. 10.1016\/j.crad.2017.12.007","journal-title":"Clin Radiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyy216","article-title":"Does stereotactic radiosurgery have a role in the management of patients presenting with 4 or more brain metastases?","volume":"84","author":"Soike MH","year":"2019","unstructured":"Soike MH, Hughes RT, Farris M, McTyre ER, Cramer CK, Bourland JD, Chan MD. Does stereotactic radiosurgery have a role in the management of patients presenting with 4 or more brain metastases?. Neurosurgery. 2019, 84:558-66. 10.1093\/neuros\/nyy216","journal-title":"Neurosurgery"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.6185","article-title":"Whole-brain radiotherapy in the management of brain metastasis","volume":"24","author":"Khuntia D","year":"2006","unstructured":"Khuntia D, Brown P, Li J, Mehta MP. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol. 2006, 24:1295-304. 10.1200\/JCO.2005.04.6185","journal-title":"J Clin Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5668","article-title":"Ionizing radiation-induced DNA damage, response, and repair","volume":"21","author":"Santivasi WL","year":"2014","unstructured":"Santivasi WL, Xia F. Ionizing radiation-induced DNA damage, response, and repair. Antioxid Redox Signal. 2014, 21:251-9. 10.1089\/ars.2013.5668","journal-title":"Antioxid Redox Signal"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0577-4","article-title":"Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation","volume":"16","author":"Lee SY","year":"2017","unstructured":"Lee SY, Jeong EK, Ju MK, et al.. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer. 2017, 16:10. 10.1186\/s12943-016-0577-4","journal-title":"Mol Cancer"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/jon.12828","article-title":"Diffusion and perfusion MRI predicts response preceding and shortly after radiosurgery to brain metastases: a pilot study","volume":"31","author":"Shah AD","year":"2021","unstructured":"Shah AD, Shridhar Konar A, Paudyal R, et al.. Diffusion and perfusion MRI predicts response preceding and shortly after radiosurgery to brain metastases: a pilot study. J Neuroimaging. 2021, 31:317-23. 10.1111\/jon.12828","journal-title":"J Neuroimaging"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1515\/med-2021-0260","article-title":"Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC","volume":"16","author":"Ye C","year":"2021","unstructured":"Ye C, Lin Q, Jin Z, Zheng C, Ma S. Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC. Open Med (Wars). 2021, 16:1265-75. 10.1515\/med-2021-0260","journal-title":"Open Med (Wars)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-020-0295-4","article-title":"Does the application of diffusion weighted imaging improve the prediction of survival in patients with resected brain metastases? A retrospective multicenter study","volume":"20","author":"Zakaria R","year":"2020","unstructured":"Zakaria R, Chen YJ, Hughes DM, et al.. Does the application of diffusion weighted imaging improve the prediction of survival in patients with resected brain metastases? A retrospective multicenter study. Cancer Imaging. 2020, 20:16. 10.1186\/s40644-020-0295-4","journal-title":"Cancer Imaging"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-014-1439-9","article-title":"Application of diffusion-weighted magnetic resonance imaging to predict the intracranial metastatic tumor response to gamma knife radiosurgery","volume":"118","author":"Lee CC","year":"2014","unstructured":"Lee CC, Wintermark M, Xu Z, Yen CP, Schlesinger D, Sheehan JP. Application of diffusion-weighted magnetic resonance imaging to predict the intracranial metastatic tumor response to gamma knife radiosurgery. J Neurooncol. 2014, 118:351-61. 10.1007\/s11060-014-1439-9","journal-title":"J Neurooncol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/01.rli.0000119195.50515.04","article-title":"Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results","volume":"39","author":"Weber MA","year":"2004","unstructured":"Weber MA, Thilmann C, Lichy MP, et al.. Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results. Invest Radiol. 2004, 39:277-87. 10.1097\/01.rli.0000119195.50515.04","journal-title":"Invest Radiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/08465371221115341","article-title":"Diagnostic accuracy of centrally restricted diffusion sign in cerebral metastatic disease: differentiating radiation necrosis from tumor recurrence","volume":"74","author":"Puac-Polanco P","year":"2023","unstructured":"Puac-Polanco P, Zakhari N, Miller J, et al.. Diagnostic accuracy of centrally restricted diffusion sign in cerebral metastatic disease: differentiating radiation necrosis from tumor recurrence. Can Assoc Radiol J. 2023, 74:100-9. 10.1177\/08465371221115341","journal-title":"Can Assoc Radiol J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2532090007","article-title":"Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"253","author":"Barajas RF Jr","year":"2009","unstructured":"Barajas RF Jr, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2009, 253:486-96. 10.1148\/radiol.2532090007","journal-title":"Radiology"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-006-9241-y","article-title":"Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma","volume":"82","author":"Chamberlain MC","year":"2007","unstructured":"Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol. 2007, 82:81-3. 10.1007\/s11060-006-9241-y","journal-title":"J Neurooncol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6828396","article-title":"Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas","volume":"2018","author":"Zikou A","year":"2018","unstructured":"Zikou A, Sioka C, Alexiou GA, Fotopoulos A, Voulgaris S, Argyropoulou MI. Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas. Contrast Media Mol Imaging. 2018, 2018:6828396. 10.1155\/2018\/6828396","journal-title":"Contrast Media Mol Imaging"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2019.1554920","article-title":"MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis","volume":"95","author":"Crowe W","year":"2019","unstructured":"Crowe W, Wang L, Zhang Z, et al.. MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis. Int J Radiat Biol. 2019, 95:338-46. 10.1080\/09553002.2019.1554920","journal-title":"Int J Radiat Biol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-021-03879-4","article-title":"The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery","volume":"155","author":"Hainc N","year":"2021","unstructured":"Hainc N, Alsafwani N, Gao A, et al.. The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery. J Neurooncol. 2021, 155:325-33. 10.1007\/s11060-021-03879-4","journal-title":"J Neurooncol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.17.18890","article-title":"Interval change in diffusion and perfusion MRI parameters for the assessment of pseudoprogression in cerebral metastases treated with stereotactic radiation","volume":"211","author":"Knitter JR","year":"2018","unstructured":"Knitter JR, Erly WK, Stea BD, Lemole GM, Germano IM, Doshi AH, Nael K. Interval change in diffusion and perfusion MRI parameters for the assessment of pseudoprogression in cerebral metastases treated with stereotactic radiation. AJR Am J Roentgenol. 2018, 211:168-75. 10.2214\/AJR.17.18890","journal-title":"AJR Am J Roentgenol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7501","article-title":"DSC perfusion MRI-derived fractional tumor burden and relative CBV differentiate tumor progression and radiation necrosis in brain metastases treated with stereotactic radiosurgery","volume":"43","author":"Kuo F","year":"2022","unstructured":"Kuo F, Ng NN, Nagpal S, et al.. DSC perfusion MRI-derived fractional tumor burden and relative CBV differentiate tumor progression and radiation necrosis in brain metastases treated with stereotactic radiosurgery. AJNR Am J Neuroradiol. 2022, 43:689-95. 10.3174\/ajnr.A7501","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac070","article-title":"Dynamic susceptibility contrast MRI may contribute in prediction of stereotactic radiosurgery outcome in brain metastases","volume":"4","author":"Starck L","year":"2022","unstructured":"Starck L, Skeie BS, Moen G, Gr\u00fcner R. Dynamic susceptibility contrast MRI may contribute in prediction of stereotactic radiosurgery outcome in brain metastases. Neurooncol Adv. 2022, 4:vdac070. 10.1093\/noajnl\/vdac070","journal-title":"Neurooncol Adv"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-019-1271-7","article-title":"DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife","volume":"14","author":"Morabito R","year":"2019","unstructured":"Morabito R, Alafaci C, Pergolizzi S, et al.. DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife. Radiat Oncol. 2019, 14:65. 10.1186\/s13014-019-1271-7","journal-title":"Radiat Oncol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26812","article-title":"Dynamic susceptibility MR perfusion in diagnosing recurrent brain metastases after radiotherapy: a systematic review and meta-analysis","volume":"51","author":"Kwee RM","year":"2020","unstructured":"Kwee RM, Kwee TC. Dynamic susceptibility MR perfusion in diagnosing recurrent brain metastases after radiotherapy: a systematic review and meta-analysis. J Magn Reson Imaging. 2020, 51:524-34. 10.1002\/jmri.26812","journal-title":"J Magn Reson Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142147-radiological-biomarkers-for-brain-metastases-prognosis-quantitative-magnetic-resonance-imaging-mri-modalities-as-non-invasive-biomarkers-for-the-effect-of-radiotherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:15Z","timestamp":1707508635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142147-radiological-biomarkers-for-brain-metastases-prognosis-quantitative-magnetic-resonance-imaging-mri-modalities-as-non-invasive-biomarkers-for-the-effect-of-radiotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,30]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.38353","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,30]]}}}